Search

Xia Wang Phones & Addresses

  • Chapin, SC
  • Irmo, SC
  • San Diego, CA
  • 8409 Alpine Ridge Rd, San Diego, CA 92129

Professional Records

Medicine Doctors

Xia Wang Photo 1

Xia Wang

View page
Specialties:
Genetics, Medical
Work:
Moffitt Medical GroupMoffitt Cancer Center Internal Medicine
12902 Usf Magnolia Dr, Tampa, FL 33612
(888) 663-3488 (phone), (813) 745-3091 (fax)
Education:
Medical School
Peking Union Med Coll, Beijing, Beijing, China
Graduated: 1990
Languages:
English
Description:
Dr. Wang graduated from the Peking Union Med Coll, Beijing, Beijing, China in 1990. She works in Tampa, FL and specializes in Genetics, Medical.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Xia Wang
COLUMBIA INTERNATIONAL TECHNICAL EQUIPMENT AND SUPPLIES, LLC
Professional Equipment, Nec, Nsk · Whol Professional Equip Mfg Lab Apparatus/Furn Mfg Elec Mach/Equip/Supp Mfg Abrasive Products Mfg Pressed/Blown Glass
108 Stonemill Ct, Irmo, SC 29063

Publications

Us Patents

Compounds And Compositions As Protein Kinase Inhibitors

View page
US Patent:
7371750, May 13, 2008
Filed:
Jul 29, 2004
Appl. No.:
10/909227
Inventors:
Taebo Sim - San Diego CA, US
Hyun Soo Lee - San Diego CA, US
Pingda Ren - San Diego CA, US
Qiang Ding - San Diego CA, US
Guobao Zhang - San Diego CA, US
Yi Liu - San Diego CA, US
Xia Wang - San Diego CA, US
Tetsuo Uno - San Diego CA, US
Bing Li - San Diego CA, US
Lintong Li - San Diego CA, US
Nathanael Schiander Gray - San Diego CA, US
Shuli You - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
A61K 31/5355
A61K 31/53
A61K 31/497
A61K 31/513
C07D 413/12
C07D 253/065
C07D 487/04
C07D 413/14
A61P 35/00
C07D 471/04
US Classification:
5142342, 514242, 51425216, 5142621, 544112, 544118, 544182, 544256, 544279, 544 81
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, Bmx, c-Raf, Csk, Fes, FGFR, Flt3, Ikk, IR, JNK, Lck, Mkk, PKC, PKD, Rsk, SAPK, Syk, Trk, BTK, Src, EGFR, IGF, Mek, Ros and Tie2 kinases.

Compounds And Compositions As Protein Kinase Inhibitors

View page
US Patent:
7423038, Sep 9, 2008
Filed:
Jun 23, 2005
Appl. No.:
11/570661
Inventors:
Pingda Ren - San Diego CA, US
Xia Wang - San Diego CA, US
Nathanael Schiander Gray - Boston MA, US
Yi Liu - San Diego CA, US
Taebo Sim - Chestnuthill MA, US
Assignee:
IRM LLC (a Delaware Limited Liability Corporation) - Hamilton
International Classification:
A61K 31/5355
C07D 413/10
C07D 475/00
A61P 35/00
US Classification:
5142342, 514249, 544118, 544258
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders than involve abnormal activation of the Abl, Bcr-abl, Bmx, c-RAF, CSK, Fes, FGFR3, Flt3, GSK3β, IR, JNK1α 1, JNK2α 2, Lck, MKK4, MKK6, p70S6K, PDGFRα, Rsk1, SAPK2α, SAPK2β, Syk and Trkβ kinases.

Compounds And Compositions As Protein Kinase Inhibitors

View page
US Patent:
7642255, Jan 5, 2010
Filed:
Apr 8, 2008
Appl. No.:
12/099708
Inventors:
Taebo Sim - Seoul, KR
Hyun Soo Lee - San Diego CA, US
Pingda Ren - San Diego CA, US
Qiang Ding - San Diego CA, US
Yi Liu - San Diego CA, US
Bing Li - Westborough MA, US
Lintong Li - San Diego CA, US
Xia Wang - San Diego CA, US
Tetsuo Uno - San Diego CA, US
Guobao Zhang - San Diego CA, US
Nathanael Schiander Gray - Boston MA, US
Shuli You - Shanghai, CN
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 413/14
C07D 471/04
C07D 487/04
A61K 31/535
A61K 31/497
A61K 31/519
C07D 251/12
A61K 31/53
A61P 35/00
US Classification:
5142342, 514241, 51425505, 51425216, 5142641, 51425214, 5142621, 544279, 544117, 544215, 544256, 544118
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, Bmx, c-Raf, Csk, Fes, FGFR, Flt3, Ikk, IR, JNK, Lck, Mkk, PKC, PKD, Rsk, SAPK, Syk, Trk, BTK, Src, EGFR, IGF, Mek, Ros and Tie2 kinases.

Compounds And Compositions As Protein Kinase Inhibitors

View page
US Patent:
7745437, Jun 29, 2010
Filed:
Jun 9, 2005
Appl. No.:
11/628881
Inventors:
Pingda Ren - San Diego CA, US
Xia Wang - San Diego CA, US
Guobao Zhang - San Diego CA, US
Qiang Ding - San Diego CA, US
Shuli You - Shanghai, CN
Qiong Zhang - San Diego CA, US
Greg Chopiuk - San Diego CA, US
Pamela A. Albaugh - Carlsbad CA, US
Taebo Sim - San Diego CA, US
Nathanael Schiander Gray - Boston MA, US
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 403/04
A61K 31/4178
US Classification:
5142358, 514249, 51425202, 51425405, 514256, 544122, 544238, 544295, 544328
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, PDGF-R, trkB, c-SRC, BMX, FGFR3, b-RAF, ΣΓK, Tιε2, Λχκ, θNK2α2, MKK4, c-RAF, MKK6, SAPK2α and SAPK2β kinases.

Compounds And Compositions As Protein Kinase Inhbitors

View page
US Patent:
7846923, Dec 7, 2010
Filed:
May 11, 2007
Appl. No.:
12/299687
Inventors:
Pingda Ren - San Diego CA, US
Baogen Wu - San Diego CA, US
Guobao Zhang - San Diego CA, US
Yongping Xie - San Diego CA, US
Barun Okram - San Diego CA, US
Victor Nikulin - Carlsbad CA, US
Xia Wang - San Diego CA, US
Ha-Soon Choi - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 471/00
A61K 31/54
US Classification:
5142245, 546 82
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, Bcr-Abl, Bcr-Abl(T315I), ALK, BLK, BMX, BRK, C-kit, c-RAF, CSK, c-SRC, EGFR, Fes, FGFR3, Flt3, Fms, Fyn, IGF-1R, IR, JAK(2), JAK(3), KDR, Lck, NLK, p70S6K, PDGFRα, Ros, SAPK2α, SGK, SIK, Syk, Tie2 and TrkB kinases.

Compounds And Compositions As Itpkb Inhibitors

View page
US Patent:
8178526, May 15, 2012
Filed:
Jun 12, 2008
Appl. No.:
12/664651
Inventors:
Badry Bursulaya - San Diego CA, US
Dai Cheng - San Diego CA, US
Jiqing Jiang - San Diego CA, US
Donald S. Karanewsky - Escondido CA, US
Yi Liu - San Diego CA, US
Shifeng Pan - San Diego CA, US
Yongqin Wan - Irvine CA, US
Xia Wang - San Diego CA, US
Yun Feng Xie - San Diego CA, US
Yang Yang - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 413/02
C07D 413/14
A61K 31/536
A61K 31/551
US Classification:
5142305, 51425213, 51425305, 51425306, 544 92, 544105, 544359, 544363
Abstract:
The invention provides a novel class of compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or dysregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1,4,5-trisphosphate 3-kinase B (ITPKb).

Compounds And Compositions As Protein Kinase Inhibitors

View page
US Patent:
8202876, Jun 19, 2012
Filed:
Sep 24, 2007
Appl. No.:
12/444129
Inventors:
Pamela Albaugh - Carlsbad CA, US
Gregory B. Chopiuk - San Diego CA, US
Qiang Ding - San Diego CA, US
Shenlin Huang - San Diego CA, US
Zuosheng Liu - San Diego CA, US
Shifeng Pan - San Diego CA, US
Pingda Ren - San Diego CA, US
Xia Wang - San Diego CA, US
Xing Wang - San Diego CA, US
Yongping Xie - San Diego CA, US
Chengzhi Zhang - San Diego CA, US
Qiong Zhang - Union City CA, US
Guobao Zhang - San Diego CA, US
Daniel Poon - Oakland CA, US
Paul Renhowe - Danville CA, US
Martin Sendzik - San Mateo CA, US
Assignee:
IRM LLC - Hamilton
Novartis AG - Basel
International Classification:
C07D 401/00
C07D 403/00
C07D 405/00
C07D 409/00
C07D 411/00
C07D 413/00
C07D 417/00
C07D 419/00
C07D 231/00
C07D 403/02
A01N 43/56
A61K 31/415
US Classification:
514256, 514406, 544333, 5483641
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, ARG, BCR-Abl, BRK, EphB, Fms, Fyn, KDR, c-Kit, LCK, PDGF-R, b-Raf, c-Raf, SAPK2, Src, Tie2 and TrkB kinases.

Pyrimidine-Substituted Benzimidazole Derivatives As Protein Kinase Inhibitors

View page
US Patent:
8426404, Apr 23, 2013
Filed:
Jun 30, 2006
Appl. No.:
11/915148
Inventors:
Guobao Zhang - San Diego CA, US
Pingda Ren - San Diego CA, US
Xia Wang - San Diego CA, US
Nathanel Gray - Boston MA, US
Taebo Sim - Seoul, KR
Assignee:
Novartis AG - Basel
International Classification:
A61K 31/535
C07D 419/00
US Classification:
5142345, 514275, 514256, 544122, 544323, 544324, 544328
Abstract:
The invention provides a novel class of compounds having Formula Ia,wherein each variable is as defined; and pharmaceutical compositions comprising such compounds and methods of using such compounds for inhibiting c-Src, FGFR3, KDR and/or Lck.
Xia Wang from Chapin, SC, age ~47 Get Report